Vaidya Sane Ayurved Laboratories Limited (NSE:MADHAVBAUG)

Market Cap	1.62B
Revenue (ttm)	900.32M
Net Income (ttm)	40.52M
Shares Out	10.51M
EPS (ttm)	2.36
PE Ratio	65.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,400
Average Volume	13,060
Open	152.65
Previous Close	152.65
Day's Range	148.05 - 154.45
52-Week Range	81.10 - 175.00
Beta	0.15
RSI	65.75
Earnings Date	May 2, 2025

About NSE:MADHAVBAUG

Vaidya Sane Ayurved Laboratories Limited, together with its subsidiaries, distributes ayurvedic medicines and products in India. It operates through Sale of Product and Hospital Activity segments. The company sells medicines for arthritis and joint pains, cholesterol, diabetes, digestive, acidity, gastric, dyslipidemia, fever, cough, cold, general tonic, heart disease, hypertension/high blood pressure, liver, low glycemic index atta, obesity/weight management, piles and renal, skin, and wounds; and diet boxes, glow gorgeous cosmetics, health su...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1999
• Employees: 636
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MADHAVBAUG

Financial Performance

In 2023, NSE:MADHAVBAUG's revenue was 993.31 million, an increase of 0.16% compared to the previous year's 991.69 million. Earnings were 19.80 million, a decrease of -59.02%.